T1	Participants 102 126	herpes simplex labialis.
T2	Participants 383 412	herpes simplex labialis (HSL)
T3	Participants 492 518	international, multicentre
T4	Participants 550 604	enrolled 728 subjects with a history of recurrent HSL.
T5	Participants 615 618	351
